Detalhe da pesquisa
1.
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials.
J Allergy Clin Immunol
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431226
2.
Clinical characteristics and management of pediatric egg-induced anaphylaxis: A cross-sectional study.
Ann Allergy Asthma Immunol
; 2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38499059
3.
Milk-induced anaphylaxis among children presenting to Canadian emergency departments.
Ann Allergy Asthma Immunol
; 132(4): 512-518.e1, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38070650
4.
Prevalence of omalizumab resistant chronic urticaria and real world effectiveness of dupilumab in omalizumab refractory chronic urticaria patients: a single center experience.
Clin Exp Dermatol
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723589
5.
Cold-induced anaphylaxis triggered by drinking cold water.
Allergol Immunopathol (Madr)
; 52(2): 45-47, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459889
6.
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.
J Allergy Clin Immunol
; 152(2): 309-325, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295474
7.
A Systematic Review of Food Protein-Induced Enterocolitis Syndrome.
Int Arch Allergy Immunol
; 184(6): 567-575, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882041
8.
Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis.
Pediatr Allergy Immunol
; 34(7): e13982, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37492920
9.
Prehospital epinephrine administration for treating anaphylaxis among those with comorbid asthma: A scoping review.
Ann Allergy Asthma Immunol
; 131(1): 69-74.e1, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088194
10.
Managing anaphylaxis: Epinephrine, antihistamines, and corticosteroids: More than 10 years of Cross-Canada Anaphylaxis REgistry data.
Ann Allergy Asthma Immunol
; 131(6): 752-758.e1, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37689113
11.
Bridging knowledge gaps in paediatric chronic urticaria through a video-based educational tool.
Clin Exp Dermatol
; 48(2): 108-111, 2023 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36730510
12.
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
Allergy
; 77(3): 734-766, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536239
13.
Cold urticaria in a pediatric cohort: Clinical characteristics, management, and natural history.
Pediatr Allergy Immunol
; 33(3): e13751, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338743
14.
Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: The McGill University Health Centre experience.
Ann Allergy Asthma Immunol
; 129(2): 182-188.e1, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35609744
15.
Economic burden of food allergy in Canada: Estimating costs and identifying determinants.
Ann Allergy Asthma Immunol
; 129(2): 220-230.e6, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35500863
16.
Tree nut-induced anaphylaxis in Canadian emergency departments: Rate, clinical characteristics, and management.
Ann Allergy Asthma Immunol
; 129(3): 335-341, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35718284
17.
Sesame-induced anaphylaxis in pediatric patients from the cross-Canada anaphylaxis registry.
Ann Allergy Asthma Immunol
; 129(3): 342-346, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697193
18.
Seafood-induced anaphylaxis in children presenting to Canadian emergency departments: Rates, clinical presentation, and management.
Ann Allergy Asthma Immunol
; 128(5): 583-588, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172181
19.
Urticaria and angioedema in children and adolescents: diagnostic challenge.
Allergol Immunopathol (Madr)
; 50(S Pt 1): 17-29, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35726487
20.
Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of Efficacy and Safety.
J Cutan Med Surg
; 26(4): 404-413, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35379011